Angela D. Ritter
Expertise in
1
conditions

Dr. Angela D. Ritter

Family Medicine
2030 Windward Lane, 
Gainesville, GA 
Accepting New Patients
Expertise in
1
conditions
2030 Windward Lane, 
Gainesville, GA 

Overview

Angela Ritter is a primary care provider, practicing in Family Medicine in Gainesville, Georgia.

Dr. Ritter is highly rated in 1 condition, according to our data. Her clinical expertise encompasses High Cholesterol, Hypertension, Familial Hypertension, and Glucocorticoid-Remediable Aldosteronism.

Dr. Ritter is board certified in American Board Of Family Medicine, Family Medicine - 1997. She is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 9 clinical trials. Dr. Ritter is currently accepting new patients.

Specialties

Family Medicine

Licenses

Family Medicine in GA

Board Certifications

American Board Of Family Medicine, Family Medicine - 1997

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

Center for Advanced Research & Education
2030 Windward Lane, Gainesville, GA 30501

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: August 26, 2026
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
A Phase 2 Randomized, Double-blind, Placebo-controlled Trial and Open Label Extension to Evaluate the Safety and Efficacy of Deupirfenidone (LYT-100) in Post-acute COVID-19 Respiratory Disease
A Phase 2 Randomized, Double-blind, Placebo-controlled Trial and Open Label Extension to Evaluate the Safety and Efficacy of Deupirfenidone (LYT-100) in Post-acute COVID-19 Respiratory Disease
Enrollment Status: Terminated
Publish Date: June 23, 2026
Intervention Type: Drug, Other
Study Drug: Deupirfenidone
Study Phase: Phase 2
A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: January 21, 2026
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
A Randomized, Open-Label, Parallel-Group, Two-Arm, Phase 4 Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared With Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diabetes
A Randomized, Open-Label, Parallel-Group, Two-Arm, Phase 4 Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared With Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diabetes
Enrollment Status: Active_not_recruiting
Publish Date: December 12, 2025
Intervention Type: Drug
Study Phase: Phase 4
A Phase 2b/3, Randomized, Double Blind, Placebo Controlled, Adaptive Design Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19)
A Phase 2b/3, Randomized, Double Blind, Placebo Controlled, Adaptive Design Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19)
Enrollment Status: Completed
Publish Date: October 15, 2025
Intervention Type: Drug
Study Drug: Leronlimab
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Evaluate the Safety and Efficacy of Three Dose Strengths of T3D-959 in Subjects With Mild-to-Moderate Alzheimer's Disease
A Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Evaluate the Safety and Efficacy of Three Dose Strengths of T3D-959 in Subjects With Mild-to-Moderate Alzheimer's Disease
Enrollment Status: Completed
Publish Date: July 19, 2024
Intervention Type: Drug
Study Drug: T3D-959
Study Phase: Phase 2
A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Leronlimab in Patients Experiencing Prolonged Coronavirus Disease 2019 (COVID-19) Symptoms [Long-Haulers]
A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Leronlimab in Patients Experiencing Prolonged Coronavirus Disease 2019 (COVID-19) Symptoms [Long-Haulers]
Enrollment Status: Completed
Publish Date: April 11, 2024
Intervention Type: Drug
Study Drug: Leronlimab
Study Phase: Phase 2
A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate Coronavirus Disease 2019 (COVID-19)
A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate Coronavirus Disease 2019 (COVID-19)
Enrollment Status: Completed
Publish Date: January 04, 2023
Intervention Type: Drug
Study Drug: Leronlimab
Study Phase: Phase 2
A Prospective, Multi-Center, Randomized Controlled, Parallel Group, Trial Evaluating the Use of AmnioExcel Plus Placental Allograft Membrane for the Management of Diabetic Foot Ulcers
A Prospective, Multi-Center, Randomized Controlled, Parallel Group, Trial Evaluating the Use of AmnioExcel Plus Placental Allograft Membrane for the Management of Diabetic Foot Ulcers
Enrollment Status: Withdrawn
Publish Date: November 02, 2021
Intervention Type: Other
Study Phase: Not Applicable
View 8 Less Clinical Trials

1 Total Publications

Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome.
Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: September 23, 2021
Similar Doctors
Expertise in
48
conditions
Dr. Sinan J. Haddad
Family Medicine
Expertise in
48
conditions
Dr. Sinan J. Haddad
Family Medicine

Guilford Immediate Care

1250 Jesse Jewell Parkway Southeast, Suite 300, 
Gainesville, GA 
 (0.1 miles away)
770-532-0800
Languages Spoken:
English, Arabic, Arabic - Jordanian, Czech, Russian, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Sinan Haddad is a primary care provider, practicing in Family Medicine in Gainesville, Georgia. Dr. Haddad is highly rated in 48 conditions, according to our data. His clinical expertise encompasses Tracheitis, Avian Influenza, Sinusitis, and Cellulitis. Dr. Haddad is board certified in American Board Of Family Medicine, Family Medicine - 2005. Dr. Haddad is currently accepting new patients.

Expertise in
8
conditions
Dr. Daniel M. Halperin
Family Medicine
Expertise in
8
conditions
Dr. Daniel M. Halperin
Family Medicine

Winship Cancer Institute Of Emory University

36 Linden Ave NE, 
Atlanta, GA 
 (50.1 miles away)
404-778-1900
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Daniel Halperin is a primary care provider, practicing in Family Medicine in Atlanta, Georgia. Dr. Halperin is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Carcinoid Syndrome, Pancreatic Islet Cell Tumor, and Metastatic Insulinoma. Dr. Halperin is board certified in American Board Of Internal Medicine - Medical Oncology, 2015. Dr. Halperin is currently accepting new patients.

Expertise in
255
conditions
Dr. James A. Yost
Family Medicine
Expertise in
255
conditions
Dr. James A. Yost
Family Medicine

Office

3425 Buford Dr Ste 200, 
Buford, GA 
 (17.7 miles away)
678-546-0200
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

James Yost is a primary care provider, practicing in Family Medicine in Buford, Georgia. Dr. Yost is highly rated in 255 conditions, according to our data. His clinical expertise encompasses Tracheitis, H1N1 Influenza, Flu, and Sinusitis. Dr. Yost is currently accepting new patients.

Frequently Asked Questions about Dr. Angela D. Ritter

How do I make an appointment with Dr. Angela D. Ritter?

You can book an appointment with Dr. Angela D. Ritter by calling their office at 770-534-5154. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Angela D. Ritter a top-rated expert for High Cholesterol?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Angela D. Ritter is classified as an Advanced expert for High Cholesterol, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Angela D. Ritter specialize in?

While Dr. Angela D. Ritter is a Family Medicine, they have specific expertise in High Cholesterol, Hypertension, and Familial Hypertension. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Family Medicine.

Does Dr. Angela D. Ritter participate in research or clinical trials?

Yes. Dr. Angela D. Ritter has published 1 articles and abstracts on conditions like High Cholesterol. You can view a list of Dr. Angela D. Ritter's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Angela D. Ritter accept my insurance?

Dr. Angela D. Ritter accepts most major insurance plans, including Aetna and Alliant Health. We recommend calling the office directly at 770-534-5154 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ritter's expertise for a condition
ConditionClose
      View All 42 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile